Search Within

Rym Benayed

Formats
  1. Journal Article (98)
  2. Meeting Abstract (88)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (183)
  2. GSK Faculty (158)
  3. Human Oncology and Pathogenesis Program (147)
  4. Tow Center for Developmental Oncology (TCDO) (144)
  5. Department of Medicine (121)
  6. Solid Tumor Oncology Division (105)

More Groups

People
  1. Marc Ladanyi (128)
  2. Maria Arcila (99)
  3. Ahmet Zehir (75)
  4. Michael Berger (67)
  5. Alexander Drilon (46)
  6. David Hyman (36)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (24)
  5. 2021 (24)
  6. 2020 (32)

More Years

Publications
  1. Journal of Molecular Diagnostics (33)
  2. Modern Pathology (32)
  3. Laboratory Investigation (16)
  4. Cancer Research (10)
  5. Clinical Cancer Research (10)
  6. JCO Precision Oncology (10)

More Publications

Publishers
  1. Elsevier Science, Inc. (33)
  2. Nature Research (32)
  3. American Association for Cancer Research (28)
  4. Nature Publishing Group (25)
  5. American Society of Clinical Oncology (16)
  6. Elsevier Inc. (9)

More Publishers

Results (188)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of molecular alterations using a targeted RNA sequencing approach in uterine mesenchymal tumors
    Meeting Abstract

    Maldonado, L.; Momeni Boroujeni, A.; Benayed, R.; Hensley, M.; Ladanyi, M.; Park, K.; Soslow, R.; Chiang, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • High NTRK3 expression in high-grade endometrial stromal sarcomas with BCOR abnormalities
    Meeting Abstract

    Momeni Boroujeni, A.; Benayed, R.; Hensley, M.; Antonescu, C.; Ladanyi, M.; Chiang, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Androgen receptor splicing variant-7 in breast carcinoma: Clinical and pathologic correlations
    Meeting Abstract

    Ferguson, D.; Mata, D.; Chandarlapaty, S.; Brogi, E.; Ladanyi, M.; Arcila, M.; Benayed, R.; Ross, D.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Targetable alterations and rare fusions in sarcomas identified by custom RNA sequencing
    Meeting Abstract

    Mata, D.; Benayed, R.; Mullaney, K.; Rios, K.; Agaram, N.; Arcila, M.; Ladanyi, M.; Hameed, M.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Complete pathological response to crizotinib in a patient with ALK-rearranged lung adenocarcinoma
    Journal Article

    Mattar, M. S.; Chang, J.; Benayed, R.; Halpenny, D.; Powers, A.; Kleiner, D. E.; Drilon, A.; Kris, M. G.
    Clinical Lung Cancer (2020)

    Fulltext@MSK | Save
  • NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls
    Journal Article

    Solomon, J. P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E. Y.; Frosina, D.; Jungbluth, A. A.; Zehir, A.; Benayed, R.; Drilon, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Genomic profiling identifies association of IDH1/IDH2 mutation with longer relapse-free and metastasis-free survival in high-grade chondrosarcoma
    Journal Article

    Zhu, G. G.; Nafa, K.; Agaram, N.; Zehir, A.; Benayed, R.; Sadowska, J.; Borsu, L.; Kelly, C.; Tap, W. D.; Fabbri, N.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save